CEMPRA HLDGS (NQ:CEMP)
Delayed: 6.88 +0.03 (0.44%)
Trade Now!
Previous Close $6.85    52 Week High $9.56 
Open $6.80    52 Week Low $5.26 
Day High $6.90    P/E N/A 
Day Low $6.67    EPS $-1.37 
Volume 39,950       


May 20, 2013 08:00 AM Cempra Presents Post-Phase 2 Analysis of Solithromycin's Efficacy and Safety Results from Patients with Community Acquired Bacterial Pneumonia (CABP)
May 17, 2013 07:25 AM Jefferies Starts Cempra, Inc. (CEMP) at Buy
May 14, 2013 08:01 AM Form 8-K CEMPRA, INC. For: May 08
May 13, 2013 04:05 PM Cempra, Inc. Signs Exclusive License and Development Agreement for Solithromycin with Toyama Chemical Co., Ltd., a subsidiary of FUJIFILM Holdings Corporation in Japan
Apr 26, 2013 07:01 PM Cempra to Present Data on Solithromycin's (CEM-101) Potential Against Urogenital Infections and Multidrug-Resistant Pathogens at ECCMID
Apr 25, 2013 05:02 PM Form 10-Q CEMPRA, INC. For: Mar 31
Apr 25, 2013 04:11 PM Form 8-K CEMPRA, INC. For: Apr 25
Apr 25, 2013 04:05 PM Cempra, Inc. Reports First Quarter 2013 Financial and Operating Results
Apr 24, 2013 04:05 PM Cempra, Inc. to Present at 12th Annual Needham Healthcare Conference
Apr 18, 2013 04:05 PM Cempra, Inc. to Report First Quarter 2013 Financial and Operating Results, and Host Conference Call and Webcast on April 25, 2013
View All Articles

Entities mentioned with CEMP

View All Entities